Last reviewed · How we verify
Universidade Estadual Paulista Júlio de Mesquita Filho — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
1 Phase 3
0 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| General anesthesia | General anesthesia | marketed | General anesthetic | Anesthesiology | ||
| Chlorhexidine rinse | Chlorhexidine rinse | marketed | Antimicrobial oral rinse | Bacterial cell membrane and proteins | Oral health / Dentistry | |
| Lactobacillus reuteri Oral Drops | Lactobacillus reuteri Oral Drops | phase 3 | Probiotic | Gastroenterology / Immunology |
Therapeutic area mix
- Anesthesiology · 1
- Gastroenterology / Immunology · 1
- Oral health / Dentistry · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Seoul National University Hospital · 2 shared drug classes
- BioBalance Corporation · 1 shared drug class
- Chung-Ang University Gwangmyeong Hospital · 1 shared drug class
- CD Pharma India Pvt. Ltd. · 1 shared drug class
- CHU de Quebec-Universite Laval · 1 shared drug class
- Chuncheon Sacred Heart Hospital · 1 shared drug class
- Biocodex · 1 shared drug class
- Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Universidade Estadual Paulista Júlio de Mesquita Filho:
- Universidade Estadual Paulista Júlio de Mesquita Filho pipeline updates — RSS
- Universidade Estadual Paulista Júlio de Mesquita Filho pipeline updates — Atom
- Universidade Estadual Paulista Júlio de Mesquita Filho pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Universidade Estadual Paulista Júlio de Mesquita Filho — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidade-estadual-paulista-j-lio-de-mesquita-filho. Accessed 2026-05-17.